Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 24, 2008

Drug Name	Review Type	Class	Manufacturer
Patanase	New Drug Initial Review	Nasal Preparations � Other	Alcon
Requip XL	New Drug Initial Review	Antiparkinson Agents	GlaxoSmithKline
Bystolic	New Drug Initial Review	Beta Blocker	Forest
Evamist	New Drug Initial Review	Hormone Replacement Therapy	Ther-Rx
Zamicet	New Drug Initial Review	Narcotics	Hawthorne
Treximet	New Drug Appeal	Triptans � Combination	GlaxoSmithKline
Cimzia	New Drug Appeal	Biologic Response Modifiers	UCB
Suprax Susp	PDL Appeal	Antibiotics � Cephalosporins	Lupin
Symbicort	PDL Appeal	Inhaled Steroids	AstraZeneca
Baraclude	PDL Appeal	Hepatitis B Agents	Bristol-Myers Squibb
Vytorin	PDL Appeal	Statin Combination	Merck Schering Plough